Caloric restriction mimetics rewire the AMPK–mTOR–ULK1 signaling nexus to restore autophagic proteostasis in the aging brain

The memory- and cognition-facilitating effects of spermidine in aging and aging-related disorders

10.1016/j.arr.2025.102787 · doi-reference

Role of autophagy mediated by AMPK/DDiT4/mTOR axis in HT22 cells under oxygen and glucose deprivation/reoxygenation

10.1021/acsomega.2c07280 · doi-reference

MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis

10.4161/auto.27710 · doi-reference

Development of a brain-targeted nano drug delivery system to enhance the treatment of neurodegenerative effects of resveratrol

10.1080/08982104.2023.2290050 · doi-reference

The effects of caloric restriction and its mimetics in Alzheimer’s disease through autophagy pathways

10.1039/c9fo02611h · doi-reference

The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation

10.1523/jneurosci.1870-13.2014 · doi-reference

Autophagy gone awry in neurodegenerative diseases

10.1038/nn.2575 · doi-reference

Urolithin A in health and diseases: prospects for Parkinson’s disease management

10.3390/antiox12071479 · doi-reference

mTOR: more targets of resveratrol?

10.1017/erm.2013.11 · doi-reference

High absorption but very low bioavailability of oral resveratrol in humans

10.1124/dmd.104.000885 · doi-reference

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

10.1212/wnl.0000000000002035 · doi-reference

Mechanisms and early efficacy data of caloric restriction and caloric restriction mimetics in neurodegenerative disease

10.1016/j.neuroscience.2025.01.004 · doi-reference

Clinical insights on caloric restriction mimetics for mitigating brain aging and related neurodegeneration

10.1007/s10571-024-01493-2 · doi-reference

Effects of late-life caloric restriction on age-related alterations in the rat cortex and hippocampus

10.3390/nu13010232 · doi-reference

Aging hallmarks and progression and age-related diseases: a landscape view of research advancement

10.1021/acschemneuro.3c00531 · doi-reference

The target of rapamycin and mechanisms of cell growth

10.3390/ijms19030880 · doi-reference

Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage

10.1073/pnas.1014715108 · doi-reference

Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status

10.1007/s00125-011-2311-5 · doi-reference

Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer’s disease

10.1371/journal.pone.0009979 · doi-reference

Quercetin attenuates LTA-induced tight junction disruption in mammary epithelial cells by modulating autophagy via the AMPK/mTOR pathway

10.1016/j.molimm.2026.04.015 · doi-reference

Mitophagy in Alzheimer’s disease and other metabolic disorders: a focus on mitochondrial-targeted therapeutics

10.1016/j.arr.2025.102732 · doi-reference

Caloric restriction mimetics improve gut microbiota: a promising neurotherapeutics approach for managing age-related neurodegenerative disorders

10.1007/s10522-024-10128-4 · doi-reference

Calorie restriction mimetic drugs could favorably influence gut microbiota leading to lifespan extension

10.1007/s11357-023-00851-0 · doi-reference

Molecular mechanism of caloric restriction mimetics-mediated neuroprotection of age-related neurodegenerative diseases: an emerging therapeutic approach

10.1007/s10522-023-10045-y · doi-reference

TFEB links autophagy to lysosomal biogenesis

10.1126/science.1204592 · doi-reference

mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy

10.1016/j.bbcan.2025.189342 · doi-reference

Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling

10.1177/0271678x211069006 · doi-reference

Spermidine as an epigenetic regulator of autophagy in neurodegenerative disorders

10.1016/j.ejphar.2024.176823 · doi-reference

Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and α-synuclein

10.1074/jbc.m609532200 · doi-reference

Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases

10.1016/j.jconrel.2016.05.044 · doi-reference

Role of ubiquitin–proteasome and autophagy-lysosome pathways in α-synuclein aggregate clearance

10.1007/s12035-022-02897-1 · doi-reference

Interactions among mTORC, AMPK and SIRT: a computational model for cell energy balance and metabolism

10.1186/s12964-021-00706-1 · doi-reference

HTT/Huntingtin in selective autophagy and Huntington disease: a foe or a friend within?

10.1080/15548627.2015.1039219 · doi-reference

Autophagy and aging

10.1016/j.cell.2011.07.030 · doi-reference

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment

10.1038/s41583-024-00805-1 · doi-reference

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

10.1038/ng1362 · doi-reference

Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson’s disease model

10.1016/j.neuropharm.2022.108963 · doi-reference

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

10.1016/j.cmet.2012.04.003 · doi-reference

Nanodelivery strategies for caloric restriction mimetics in age-associated neurodegeneration

10.1016/j.arr.2026.103203 · doi-reference

Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer’s disease

10.3233/jad-140444 · doi-reference